OLD National Bancorp IN Has $384,000 Position in Takeda Pharmaceutical Company Limited (NYSE:TAK)

OLD National Bancorp IN reduced its holdings in Takeda Pharmaceutical Company Limited (NYSE:TAK) by 4.7% during the 4th quarter, HoldingsChannel reports. The firm owned 26,931 shares of the company’s stock after selling 1,343 shares during the quarter. OLD National Bancorp IN’s holdings in Takeda Pharmaceutical were worth $384,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors also recently made changes to their positions in the business. SG Americas Securities LLC grew its position in Takeda Pharmaceutical by 73.1% during the third quarter. SG Americas Securities LLC now owns 16,043 shares of the company’s stock worth $248,000 after buying an additional 6,775 shares in the last quarter. Caprock Group LLC boosted its holdings in Takeda Pharmaceutical by 17.3% during the third quarter. Caprock Group LLC now owns 67,276 shares of the company’s stock valued at $1,041,000 after purchasing an additional 9,906 shares in the last quarter. Aaron Wealth Advisors LLC boosted its holdings in Takeda Pharmaceutical by 39.2% during the third quarter. Aaron Wealth Advisors LLC now owns 18,403 shares of the company’s stock valued at $285,000 after purchasing an additional 5,185 shares in the last quarter. Simplicity Solutions LLC boosted its holdings in Takeda Pharmaceutical by 0.4% during the third quarter. Simplicity Solutions LLC now owns 213,515 shares of the company’s stock valued at $3,303,000 after purchasing an additional 955 shares in the last quarter. Finally, Ballentine Partners LLC boosted its holdings in Takeda Pharmaceutical by 47.3% during the third quarter. Ballentine Partners LLC now owns 19,968 shares of the company’s stock valued at $309,000 after purchasing an additional 6,412 shares in the last quarter. 9.17% of the stock is owned by institutional investors and hedge funds.

Takeda Pharmaceutical Stock Down 1.1 %

NYSE TAK opened at $13.23 on Thursday. The company has a current ratio of 1.06, a quick ratio of 0.55 and a debt-to-equity ratio of 0.64. The stock’s 50 day moving average is $14.11 and its two-hundred day moving average is $14.22. The company has a market capitalization of $41.87 billion, a price-to-earnings ratio of 20.05, a PEG ratio of 3.79 and a beta of 0.53. Takeda Pharmaceutical Company Limited has a 1-year low of $13.11 and a 1-year high of $17.11.

Takeda Pharmaceutical (NYSE:TAK) last released its quarterly earnings data on Thursday, February 1st. The company reported $0.51 earnings per share for the quarter. The company had revenue of $7.52 billion for the quarter. Takeda Pharmaceutical had a return on equity of 12.57% and a net margin of 6.90%. Equities analysts forecast that Takeda Pharmaceutical Company Limited will post 1.5 earnings per share for the current fiscal year.

Takeda Pharmaceutical Company Profile

Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived therapies, immunology, oncology, and neuroscience.